- Home
- KROS
KROS
Keros Therapeutics Inc.
as 04-18-2025 12:38pm EST
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | LEXINGTON |
| Market Cap: | N/A | IPO Year: | 2020 |
| Target Price: | $25.29 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.12 - $72.37 | Next Earning Date: | 05-07-2025 |
| Revenue: | $3,550,000 | Revenue Growth: | 2250.99% |
| Revenue Growth (this year): | 45.1% | Revenue Growth (next year): | 83.46% |
Latest Keros Therapeutics Inc. News
KROS Breaking Stock News: Dive into KROS Ticker-Specific Updates for Smart Investing
TipRanks
8 days ago
Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz
MT Newswires
9 days ago
Sector Update: Health Care Stocks Retreat Late Afternoon
MT Newswires
9 days ago
Update: Keros Therapeutics Shares Rise After Board Initiates Review of Strategic Alternatives
Pharmaceutical Technology
9 days ago
Keros Therapeutics considers sale amid investor pressure
MT Newswires
9 days ago
Sector Update: Health Care Stocks Lean Lower Premarket Thursday
MT Newswires
9 days ago
Sector Update: Health Care
MT Newswires
9 days ago
Keros Therapeutics Board Initiates Review of Strategic Alternatives
GlobeNewswire
9 days ago
Keros Therapeutics Announces Review of Strategic Alternatives
Compare KROS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KROS Keros Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.